Literature DB >> 3500824

Outcome of possible ankylosing spondylitis in a 10 years' follow-up study.

W Mau1, H Zeidler, R Mau, A Majewski, J Freyschmidt, H Deicher.   

Abstract

Of 88 selected patients with possible ankylosing spondylitis (AS) 54 (61%) participated in two phases of a 10 years' follow-up study. Thirty-two (59%) developed definite AS according to the New York criteria, 10 (19%) had possible/undifferentiated seronegative spondylarthropathy (SSA) and 12 patients had other diagnoses. Only 3 (9%) of 35 patients with sacroiliitis did not fulfill the New York criteria for definite AS until the last examination. Sacroiliitis and radiological spinal signs of AS appeared rather late above a mean age of 40 years and after a mean disease duration of more than 10 years. After 18 years mean disease duration 25 (78%) of 32 AS patients had good or sufficient functional capacity indicating an overall good functional prognosis. HLA B27 typing proved to be useful in patients with possible early AS: 29 (71%) of 41 B27 positive and 3 (23%) of 13 B27 negative patients developed definite AS (p less than 0.005). A combination of the B27 test with data of the history, clinical, laboratory, and radiological examination proposed as early diagnostic criteria detected patients with the outcome diagnosis of definite AS with even higher significance (p less than 0.001). These criteria were also useful in the identification of patients with possible or undifferentiated SSA. The recently recognized entity of undifferentiated SSA should only be diagnosed after long term follow-up.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3500824     DOI: 10.1007/BF02203386

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  11 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  Therapeutic criteria in rheumatoid arthritis.

Authors:  O STEINBROCKER; C H TRAEGER; R C BATTERMAN
Journal:  J Am Med Assoc       Date:  1949-06-25

3.  Evaluation of early diagnostic criteria including HLA-B27 for ankylosing spondylitis in a follow-up study.

Authors:  H Zeidler; R Mau; W Mau; J Freyschmidt; A Majewski; H Deicher
Journal:  Z Rheumatol       Date:  1985 Nov-Dec       Impact factor: 1.372

4.  HLA-B27 and clinical aspects of ankylosing spondylitis: results of prospective studies.

Authors:  P Wagener; W Mau; H Zeidler; G Eckert; M Robin-Winn; H Deicher
Journal:  Immunol Rev       Date:  1985-08       Impact factor: 12.988

5.  HLA B27 related 'unclassifiable' seronegative spondyloarthropathies.

Authors:  S Prakash; N K Mehra; S Bhargava; A N Malaviya
Journal:  Ann Rheum Dis       Date:  1983-12       Impact factor: 19.103

6.  Unclassified HLA-B27 inflammatory rheumatic diseases: followup of 23 patients.

Authors:  J Sany; F Rosenberg; G Panis; H Serre
Journal:  Arthritis Rheum       Date:  1980-02

7.  [Diagnostic criteria in rheumatic pelvispondylitis without radiological sacro-iliac signs. Proposals for updating].

Authors:  P Baudoin; M Landureau
Journal:  Rev Rhum Mal Osteoartic       Date:  1979-06

8.  HLA-B27 in possible ankylosing spondylitis with peripheral arthritis.

Authors:  H Zeidler; P Wagener; G Eckert; J Freyschmidt; R Fritsch; H Creutzig; H Deicher
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

9.  Clinical features and followup study of HLA-B27 positive patients presenting with peripheral arthritis.

Authors:  P Sambrook; L McGuigan; D Champion; J Edmonds; A Fleming; I Portek
Journal:  J Rheumatol       Date:  1985-06       Impact factor: 4.666

10.  Prognosis of inflammatory joint diseases. A three-year follow-up study.

Authors:  M Nissilä; H Isomäki; K Kaarela; P Kiviniemi; J Martio; S Sarna
Journal:  Scand J Rheumatol       Date:  1983       Impact factor: 3.641

View more
  5 in total

Review 1.  [Imaging of the sacroiliac joints].

Authors:  X Baraliakos; M Fruth; J Braun
Journal:  Z Rheumatol       Date:  2017-12       Impact factor: 1.372

Review 2.  Nonradiographic axial spondyloarthritis background and confounding factors of this new terminology: an appraisal.

Authors:  Jen Erbil; Luis R Espinoza
Journal:  Clin Rheumatol       Date:  2014-10-01       Impact factor: 2.980

Review 3.  Diagnosis and classification in spondyloarthritis: identifying a chameleon.

Authors:  Astrid van Tubergen; Ulrich Weber
Journal:  Nat Rev Rheumatol       Date:  2012-03-27       Impact factor: 20.543

Review 4.  Undifferentiated spondyloarthritis: recent clinical and therapeutic advances.

Authors:  Vanesa Cruzat; Raquel Cuchacovich; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2010-10       Impact factor: 4.592

5.  Percentage of progressors in imaging: can we ignore regressors?

Authors:  Alexandre Sepriano; Sofia Ramiro; Robert Landewé; Maxime Dougados; Desirée van der Heijde
Journal:  RMD Open       Date:  2019-02-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.